Real-time enrollment status for this metastatic pancreatic adenocarcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:47 AM UTC
| NCT Number | NCT06576115 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Pancreatic Adenocarcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Barbara Ann Karmanos Cancer Institute |
| Last Updated on CT.gov | November 5, 2025 (Nov 5, 2025) |
As of July 13, 2026: Clinical trial NCT06576115 is currently recruiting participants. This clinical trial study for metastatic pancreatic adenocarcinoma is actively seeking new participants at 7 locations across the United States. The study is sponsored by Barbara Ann Karmanos Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06576115 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06576115 was last updated Nov 5, 2025 (November 5, 2025). HelloStudys verifies this status automatically.